SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-23-203832
Filing Date
2023-08-04
Accepted
2023-08-04 16:01:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d531834ds3a.htm S-3/A 84394
2 EX-23.1 d531834dex231.htm EX-23.1 2450
  Complete submission text file 0001193125-23-203832.txt   87822
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-272509 | Film No.: 231143907
SIC: 2834 Pharmaceutical Preparations